News

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...
Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...
CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic health system with a global footprint, announced plans ...
Rodolphe Buet will continue to head up the distribution operation as Chief Distribution Officer of Studio TF1. Alice Damiani, ...
The Cleveland Cavaliers and Cleveland Clinic are teaming up for another 25 years — and their partnership will soon include a ...
Apple Inc. (NASDAQ: AAPL) is reportedly working on an AI-driven health coach, under the codename Project Mulberry, as a ...